“…As the biocatalytic approach necessitates nicotinamide cofactors, the use of whole-cells has been of high interest (Alphand and Wohlgemuth, 2010;Alphand et al, 2003;Baldwin et al, 2008;Fink et al, 2011;Law et al, 2006) with the supply of a carbon source to regenerate the cofactor. The self-sufficient linear cascade combining an ADH (Weckbecker and Hummel, 2006) and a cyclohexanone monooxygenase (CHMO) (Donoghue et al, 1976) for the synthesis of ECL makes the biocatalytic route very efficient since only a single substrate ends up to a single final product (Mallin et al, 2013;Scherkus et al, 2016;Schmidt et al, 2015a,b;Staudt et al, 2013). The self-sufficient linear cascade combining an ADH (Weckbecker and Hummel, 2006) and a cyclohexanone monooxygenase (CHMO) (Donoghue et al, 1976) for the synthesis of ECL makes the biocatalytic route very efficient since only a single substrate ends up to a single final product (Mallin et al, 2013;Scherkus et al, 2016;Schmidt et al, 2015a,b;Staudt et al, 2013).…”